Compare NX & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NX | IART |
|---|---|---|
| Founded | 1927 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 901.9M | 951.9M |
| IPO Year | 2008 | 1996 |
| Metric | NX | IART |
|---|---|---|
| Price | $21.16 | $13.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 12 |
| Target Price | ★ $26.00 | $15.67 |
| AVG Volume (30 Days) | 365.4K | ★ 1.2M |
| Earning Date | 12-10-2026 | 10-21-2026 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.57 | 0.19 |
| Revenue | ★ $1,837,641,000.00 | N/A |
| Revenue This Year | $1.98 | $0.55 |
| Revenue Next Year | $0.51 | $1.86 |
| P/E Ratio | ★ $38.12 | $71.84 |
| Revenue Growth | ★ 43.81 | N/A |
| 52 Week Low | $11.04 | $8.70 |
| 52 Week High | $23.33 | $20.49 |
| Indicator | NX | IART |
|---|---|---|
| Relative Strength Index (RSI) | 61.96 | 50.80 |
| Support Level | $17.79 | $10.42 |
| Resistance Level | $22.78 | $14.28 |
| Average True Range (ATR) | 0.93 | 0.66 |
| MACD | 0.27 | 0.21 |
| Stochastic Oscillator | 78.01 | 84.58 |
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.